|Test Code||C2729 / C2729-M|
|Test||CA 27.29 (BREAST), SERUM|
The Food and Drug Administration has approved CA 27.29 for serial testing in women with prior stage II or III breast cancer who are clinically free of disease.
Predicting early recurrence of disease in women with treated carcinoma of the breast
As an indication that additional tests or procedures should be performed to confirm recurrence of breast cancer
|Specimen||Draw blood in a serum gel tube or plain red top tube. Spin down and send 0.5 mL (minimum volume: 0.25 mL) of serum refrigerated in a screw-capped, plastic vial.
**Freeze if not processed within 7 days**
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged and aliquoted within 2 hours of collection
> or =18 years: < or =38.0 U/mL (use not defined)
Reference values have not been established for patients who are <18 years of age.
Serum markers are not specific for malignancy, and values may vary by method.
|Analytic Time||1 Day|
|Day(s) Test Set Up||Monday through Friday|